Rashna Madan Selected Research

Rashna Madan Research Topics

Disease

18	Neoplasms (Cancer) 02/2024 - 01/2006
6	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2006
5	Ovarian Neoplasms (Ovarian Cancer) 10/2023 - 11/2014
3	Adenocarcinoma 01/2023 - 08/2020
2	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 01/2023
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022 - 01/2020
2	Squamous Cell Carcinoma of Head and Neck 01/2020 - 11/2006
2	Lymphatic Metastasis 03/2012 - 01/2006
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 02/2024
1	Triple Negative Breast Neoplasms 11/2023
1	Pathologic Complete Response 11/2023
1	Residual Neoplasm 11/2023
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Papillomavirus Infections 01/2022
1	Primary Immunodeficiency Diseases 01/2022
1	Atrophy 05/2021
1	Gastrinoma 10/2016
1	Papillary Carcinoma 10/2016
1	Ovarian Epithelial Carcinoma 12/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2015
1	Neoplasm Metastasis (Metastasis) 03/2012
1	Serous Cystadenoma 01/2012
1	Galactocele 03/2009
1	Fibroadenoma 03/2009
1	Mastitis 03/2009
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2006
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2006
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2006

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2006
8	Biomarkers (Surrogate Marker)IBA 02/2024 - 03/2012
5	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 10/2016
4	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2019
2	cabozantinibIBA 02/2024 - 01/2023
2	durvalumabIBA 02/2024 - 01/2023
2	pembrolizumabIBA 11/2023 - 01/2023
2	Carboplatin (JM8)FDA LinkGeneric 11/2023 - 11/2014
2	ParaffinIBA 01/2022 - 11/2006
2	Progesterone FDA LinkGeneric 01/2021 - 01/2006
2	ChromatinIBA 01/2020 - 10/2016
2	Estrogen ReceptorsIBA 10/2016 - 03/2012
2	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 11/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2024
1	Docetaxel (Taxotere)FDA Link 11/2023
1	AnthracyclinesIBA 11/2023
1	Leucovorin (Folinic Acid)FDA Link 01/2023
1	Single-Chain AntibodiesIBA 01/2023
1	CyclinsIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Formaldehyde (Formol)FDA Link 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2022
1	AndrogensIBA 05/2021
1	Progesterone CongenersIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	IntegrinsIBA 01/2020
1	Matrix Metalloproteinase 16IBA 01/2020
1	PhosphoserineIBA 01/2020
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2018
1	Progestins (Progestagens)IBA 01/2018
1	EnzymesIBA 01/2018
1	SteroidsIBA 01/2018
1	GastrinsIBA 10/2016
1	Coloring Agents (Dyes)IBA 10/2016
1	AcetylglucosamineIBA 01/2016
1	Protein Tyrosine PhosphatasesIBA 12/2015
1	pleiotrophin (HARP)IBA 12/2015
1	Small Interfering RNA (siRNA)IBA 12/2015
1	nutlin 3IBA 11/2014
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 11/2014
1	Thiostrepton (Gargon)IBA 11/2014
1	human ERBB2 proteinIBA 03/2012
1	MucinsIBA 01/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2009
1	ezrinIBA 11/2006
1	moesinIBA 11/2006
1	AntigensIBA 03/2006
1	LigandsIBA 01/2006
1	AntibodiesIBA 01/2006
1	Estrogens (Estrogen)FDA Link 01/2006
1	PaxillinIBA 01/2006
1	ErbB-2 ReceptorIBA 01/2006

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 02/2024 - 12/2015
3	Therapeutics 01/2023 - 12/2015
1	Immunomodulation 01/2021
1	Nephrectomy 02/2015
1	Segmental Mastectomy (Lumpectomy) 03/2009